Introduction
============

Neurons rely on the targeted delivery of diverse RNAs to synaptodendritic microdomains for locally controlled protein synthesis ([@bib101]; [@bib42]; [@bib90]; [@bib49]; [@bib20]). RNA transport mechanisms are therefore critical underpinnings of local protein synthetic competence and, consequently, of synaptic functionality and plasticity ([@bib62]; [@bib13]; [@bib20]; [@bib24]). Dysregulated dendritic RNA transport has been implicated in the manifestation of neurological disease ([@bib41]; [@bib68]; [@bib94]; [@bib77]; [@bib73]).

Dendritically targeted RNAs include mRNAs and regulatory RNAs ([@bib25]; [@bib90]; [@bib49]; [@bib80]; [@bib38]). Dendritic mRNAs encode a variety of synaptodendritic proteins, including postsynaptic receptors, kinases, and cytoskeletal elements ([@bib62]; [@bib20]). Some of these mRNAs are delivered to dendrites in an activity-dependent manner ([@bib96], [@bib97]; [@bib23]), suggesting that neuronal stimulation can lead to increased availability of such mRNAs for local translation at the synapse. Dendritic regulatory RNAs include miRNAs ([@bib48]; [@bib51]; [@bib87]; [@bib66]) and brain cytoplasmic (BC) RNAs ([@bib69], [@bib70], [@bib72], [@bib73]). Regulatory BC RNAs are translational repressors that target translation initiation by interacting with eukaryotic initiation factors ([@bib38]). Translational control of gene expression is thus performed in synaptodendritic domains by regulatory RNAs that are selectively delivered to such sites ([@bib15]; [@bib38]).

Dendritic RNA targeting enables postsynaptic microdomains to retain relevant mRNAs for local translation. The dynamic modulation of dendritic RNA delivery is therefore a key specificity determinant for local mRNA availability and thus for the local management of synaptic protein repertoires. However, our understanding of dendritic RNA delivery mechanisms is underdeveloped as important questions have remained unanswered. At the most fundamental level, we need to (a) decipher spatial targeting codes that dendritic RNAs use to specify their destinations, (b) understand how such codes are recognized and interpreted into dendritic targeting, and (c) establish how targeting codes mediate dendritic RNA transport that is induced by neuronal activity. Despite recent progress in some of these areas ([@bib23]; [@bib13]; [@bib20]), the molecular basis of activity-dependent dendritic RNA targeting has remained elusive.

Here, we describe a novel molecular mechanism for the stimulus-inducible delivery of neuronal RNAs to dendrites. Key to targeting conditionality is the organization of noncanonical motif interactions in the RNA targeting element. We show that such noncanonical conditional targeting elements specify dendritic delivery that is inducible by neuronal stimulation and receptor activation. Underlying the conditional delivery mechanism is the Ca^2+^-dependent recognition of targeting motifs by the RNA transport factor heterogeneous nuclear RNP (hnRNP) A2. Such conditional targeting motifs are often encoded in mobile genomic elements of the retroposon type, and our work therefore also implicates genomic retroposition as an innovative force in the evolution of plastic cellular mechanisms in neurons.

Results
=======

Rationale
---------

The dendritic targeting of regulatory BC RNAs is constitutive and specified by spatial codes that use noncanonical motif interactions ([@bib70], [@bib72], [@bib73]). Noncanonical RNA motifs are those featuring nucleotide interactions that are distinct from Watson--Crick (WC) base pairing ([@bib56]; [@bib58]). BC RNA noncanonical targeting motifs are known as GA motifs as they are built around a core of two purine•purine base pairs of the G•A/A•G type ([@bib72], [@bib73]).

BC RNAs are related to recurrent genomic elements via the retroposition mechanism ([@bib38]). The dissemination of such elements, known as retroposons or retrotransposons, has been a major hallmark and driving force of mammalian phenotypic development and innovation ([@bib9]; [@bib34]; [@bib44]; [@bib18]). It is estimated that the retroposition mechanism has been responsible for the generation of more than two thirds of the human genomic content ([@bib10]; [@bib22]). A retroposon is generated by the reverse transcription of an RNA or RNA segment followed by reinsertion into the genome. If such events occur multiple times, large numbers of retroposons can potentially be generated. Depending on the point of insertion, each newly generated retroposon can have neutral, deleterious, or beneficial cellular consequences. In the case of regulatory BC1 RNA, retroposons generated from the 5′ stem-loop domain have been dispersed in rodent genomes where they typically reside in UTRs (e.g., intergenic regions, introns, 3′ UTRs, and 5′ UTRs). Such 5′ BC1 retroposons are known as identifier (ID) elements ([@bib47]). Because the 5′ BC1 domain harbors a noncanonical GA targeting motif, we reasoned that a 5′ BC1-derived ID element, inserted for instance in the 3′ UTR of a protein-coding gene, will confer dendritic targeting competence on the respective mRNA. Consistent with this notion, intron-residing ID elements have recently been found to be targeting competent if retained in cytoplasmic transcripts ([@bib13]).

Activity-dependent targeting
----------------------------

ID elements, retroposed from the 5′ BC1 domain, are categorized in four subtypes in rat (ID1--ID4; [Fig. 1](#fig1){ref-type="fig"}; [@bib47]). We generated chimeric reporter mRNAs in which ID elements of each of the four subtypes were introduced 3′ to the coding region of α-tubulin mRNA, an mRNA that is normally restricted to neuronal somata ([@bib12]; [@bib64]; [@bib73]). While ID1 is identical to the 5′ BC1 domain, ID2 differs from the 5′ BC1 domain only inasmuch as a G·U wobble WC pair in the basal stem has been replaced with a G=C standard WC pair ([Fig. 1](#fig1){ref-type="fig"}). In either case, the noncanonical GA targeting motif is identical to the one contained in the 5′ BC1 domain, and we therefore anticipated that reporter mRNAs that harbor ID1 or ID2 elements would be constitutively delivered to dendrites. This was indeed observed in RNA transport assays ([Fig. 2, A--D and I](#fig2){ref-type="fig"}) in which we assessed RNA transport competence using our standard microinjection protocol with sympathetic neurons in primary culture ([@bib69], [@bib72], [@bib73]).

![**Secondary structures of the 5′ BC1 domain and ID1--ID4 elements.** Rat consensus sequences ([@bib47]) are shown. Secondary structure representation is based on previous evidence ([@bib85]; [@bib72], [@bib73]). Base pairs are denoted as follows: =, GC standard WC; --, AU standard WC, ·, GU wobble WC; •, noncanonical (non-WC). GA motif structures are bracketed by vertical bars. Noncanonical purine•purine base pairs (A•A, A•G, G•A, and G•G) are shown in red. GA motif WC base pairs clamping the noncanonical GA motif core are shown in blue. Differences between ID elements and the 5′ BC1 domain are indicated by arrows. The 5′ BC1 domain and ID1 are identical; 5′ BC1 nucleotide numbering is shown.](JCB_201310045_Fig1){#fig1}

![**Dendritic transport of ID-chimeric α-tubulin mRNAs under basal conditions.** Sympathetic neurons in primary culture (nonstimulated) were microinjected with chimeric reporter mRNAs as noted in the images. Chimeric mRNAs contained the α-tubulin protein-coding sequence, an ID element, and an A98 poly(A) tail, as indicated. (A--H) Photomicrographs show subcellular localization of injected RNAs. In this figure (and in most of the following figures showing photomicrographs), dark-field images are on the left, and corresponding phase-contrast photomicrographs are depicted on the right. RNA signal appears as white silver grains in dark-field photomicrographs. Chimeric mRNAs containing ID1 or ID2 elements (A--D) were targeted to distal dendritic domains, whereas chimeric mRNAs containing ID3 or ID4 elements (E--H) were not. Number of cells analyzed: (A and B) 12 neurons, 41 dendrites; (C and D) 15 neurons, 49 dendrites; (E and F) 21 neurons, 79 dendrites; (G and H) 17 neurons, 58 dendrites. Bar, 50 µm. (I) Quantitative analysis. One-way analysis of variance (ANOVA), Dunnett's post hoc analysis (comparison of levels of ID1-chimeric α-tubulin mRNA with levels of other ID-chimeric α-tubulin mRNA forms): comparison with ID2-chimeric α-tubulin mRNA (C and D), P \> 0.5 for interval points 50 µm; comparison with ID3-chimeric α-tubulin mRNA (E and F), P \< 0.001 for all interval points; comparison with ID4-chimeric α-tubulin mRNA (G and H), P \< 0.001 for all interval points. Quantitative data in this and the following figures are given in the format means ± SEM; error bars indicate SEM.](JCB_201310045_Fig2){#fig2}

ID3 and ID4, in comparison with ID1 and ID2, feature additional noncanonical content (G•G or A•G, respectively) that is directly juxtaposed with the GA targeting motif at relative position 35--41 in the apical stem-loop domain ([Fig. 1](#fig1){ref-type="fig"}). Surprisingly, and in contrast to chimeric mRNAs carrying ID1 or ID2 elements, chimeric mRNAs carrying ID3 or ID4 elements were not delivered to dendrites ([Fig. 2, E--H and I](#fig2){ref-type="fig"}). We conclude that the constitutive targeting competence of the 5′ BC1 domain is retained in ID1 and ID2, but not in ID3 or ID4, elements.

We hypothesized, as will be detailed in the following paragraphs, that conversion of the base pair at relative position 35--41 ([Fig. 1](#fig1){ref-type="fig"}) from canonical 35G=C41 (5′ BC1, ID1, and ID2) to noncanonical 35G•G41 (ID3) or 35A•G41 (ID4) will alter, but not abolish, the dendritic coding competence of the adjoining GA motif. Because the aforementioned experiments were conducted with neurons under basal steady-state (resting) conditions, we now asked whether ID3 or ID4 chimeric mRNAs are targeted to dendrites upon neuronal stimulation. To this end, we used elevated K^+^ to depolarize sympathetic neurons in culture, as previously described ([@bib93]; [@bib3]; [@bib31]; see also Materials and methods). [Fig. 3](#fig3){ref-type="fig"} shows that upon K^+^-induced depolarization, ID3 and ID4 α-tubulin chimeric mRNAs were indeed delivered to dendrites, and resulting somatodendritic distributions were indistinguishable from that of ID1 (5′ BC1) and ID2 α-tubulin chimeric mRNA under nonstimulated (basal) steady-state conditions. The data indicate that a noncanonical purine•purine (R•R) base pair adjoining a noncanonical GA targeting motif can render dendritic transport conditional. We refer to such motifs as R•R-linked GA targeting motifs, and we suggest that such motifs define a class of mRNAs that are conditionally targeted to dendrites.

![**Dendritic transport of ID3- and ID4-chimeric mRNAs in stimulated neurons.** (A--D) Sympathetic neurons in culture were K^+^ depolarized before RNA microinjection. Under these conditions, ID3 (A and B)- and ID4 (C and D)-chimeric α-tubulin mRNAs were delivered to distal dendrites. Number of cells analyzed: (A and B) 16 neurons, 55 dendrites; (C and D) 18 neurons, 60 dendrites. Bar, 50 µm. (E) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels in the basal, nonstimulated state \[[Fig. 2](#fig2){ref-type="fig"}\] with RNA levels after K^+^ depolarization): ID3-chimeric α-tubulin mRNA (A and B), P \< 0.001 for all interval points; ID4-chimeric α-tubulin mRNA (C and D), P \< 0.001 for all interval points. Error bars indicate SEM.](JCB_201310045R_Fig3){#fig3}

In control experiments, we used a chimeric mRNA with a reverse complementary ID4 element (ID4R), resulting in a configuration that is antisense to ID4. In ID4R elements, standard WC base pairs are retained (e.g., conversion of G=C to C=G), whereas noncanonical pairs are disrupted (e.g., G•A to C U), thus resulting in a stem loop that lacks a GA motif. No significant dendritic targeting was observed with ID4R α-tubulin mRNA in either basal or stimulated states ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.201310045/DC1){#supp1}).

We performed a further set of experiments to test the hypothesis that noncanonical interactions at relative position 35--41 render dendritic targeting conditional. We asked whether the constitutive dendritic targeting competence of wild-type (WT) BC1 RNA can be altered to conditional, i.e., activity dependent, by introducing ID-type point mutations. We converted, in full-length BC1 RNA, WT canonical base pair G35=C41 to mutant noncanonical variant G35•G41 or A35•G41, the former corresponding to ID3 and the latter corresponding to ID4 ([@bib47]). We found that G35•G41 and A35•G41 mutant BC1 RNAs both lack dendritic targeting competence under basal conditions but are delivered along the entire dendritic extent upon depolarization ([Fig. 4](#fig4){ref-type="fig"}). In contrast, conversion of wobble WC pairs to standard WC pairs in the basal stem, as indicated in [Fig. 1](#fig1){ref-type="fig"}, did not alter the constitutive targeting competence of BC1 RNA (not depicted). The data confirm that noncanonical attributes in relative position 35--41 are determinants of targeting conditionality.

![**Mutant BC1 RNA in conditional dendritic delivery.** (A--D) WT BC1 RNA (G35=C41) is constitutively targeted to dendrites of sympathetic neurons in culture ([@bib69], [@bib72], [@bib73]). (A and C) In contrast, mutant A35•G41 BC1 RNA and mutant G35•G41 BC1 RNA were not transported under basal conditions. (B and D) Both mutant BC1 RNA forms were, however, delivered to dendrites upon K^+^ depolarization. Number of cells analyzed: (A) 18 cells, 57 dendrites; (B) 17 cells, 56 dendrites; (C) 16 cells, 52 dendrites; (D) 16 cells, 44 dendrites. Bar, 50 µm. (E) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of levels of mutant BC1 RNAs in the basal state with levels after K^+^ depolarization): BC1 RNA A35•G41 (A and B), P \< 0.001 for all interval points; BC1 RNA G35•G41 (C and D), P \< 0.001 for all interval points. Error bars indicate SEM.](JCB_201310045_Fig4){#fig4}

Dendritic targeting induced by receptor activation
--------------------------------------------------

The aforementioned data on dendritic delivery after depolarization raise the question whether transport can also be induced by specific receptor activation. Noting that sympathetic neurons use adrenergic transmission ([@bib52]), we used adrenergic agonists and antagonists to address this question. ID4 α-tubulin mRNA, which is not targeted to dendrites under basal steady-state conditions ([Fig. 2](#fig2){ref-type="fig"}), was delivered along the entire dendritic extent upon activation of β-adrenergic receptors (ARs) using the β-AR agonist isoproterenol ([Fig. 5, A, B, and G](#fig5){ref-type="fig"}). In contrast, ID4 α-tubulin mRNA remained restricted to somata after application of the α-adrenergic agonist phenylephrine ([Fig. 5, C, D, and H](#fig5){ref-type="fig"}). Induction of dendritic transport by isoproterenol was blocked by the β-adrenergic antagonist propranolol ([Fig. 6, E, F, and H](#fig6){ref-type="fig"}). Analogous results were obtained with ID3-mediated conditional dendritic transport (unpublished data). The data indicate that ID3- and ID4-mediated conditional dendritic transport is specifically induced by activation of β-ARs.

![**Dendritic transport of ID4-chimeric mRNA after β-adrenergic activation.** (A and B) After β-adrenergic activation with the agonist isoproterenol, ID4-chimeric α-tubulin mRNA was delivered to distal dendrites of sympathetic neurons. (C and D) In contrast, after α-adrenergic activation with the agonist phenylephrine, ID4-chimeric α-tubulin mRNA was not transported to dendrites to any substantial extent. (E and F) Application of the β-AR antagonist propranolol before application of agonist isoproterenol blocked the isoproterenol-induced dendritic delivery of ID4-chimeric α-tubulin mRNA. Concentrations of agonists, antagonists, and other drugs are given in Materials and methods. Number of cells analyzed: (A and B) 16 cells, 52 dendrites; (C and D) 16 cells, 57 dendrites; (E and F) 14 cells, 50 dendrites. Bar, 50 µm. (G) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels in the basal state \[[Fig. 2](#fig2){ref-type="fig"}\] with RNA levels after adrenergic activation/blockade): comparison with phenylephrine (A and B), P \> 0.7 for interval points 50 µm; comparison with isoproterenol (C and D), P \< 0.001 for all interval points; comparison with isoproterenol/propranolol (E and F), P \> 0.8 for interval points 50 µm. Error bars indicate SEM.](JCB_201310045_Fig5){#fig5}

![**Conditional dendritic transport of CLN2 mRNA.** (A and B) ID3-containing CLN2 mRNA was not targeted to dendrites of sympathetic neurons under basal conditions. (C--F) CLN2 mRNA was delivered to dendrites after β-AR activation with agonist isoproterenol (C and D) but not after α-adrenergic activation with agonist phenylephrine (E and F). Number of cells analyzed: (A and B) 19 cells, 72 dendrites; (C and D) 17 cells, 63 dendrites; (E and F) 18 cells, 66 dendrites. Bar, 50 µm. (G) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels in the basal state with RNA levels after adrenergic activation): comparison with isoproterenol (C and D), P \< 0.001 for all interval points; comparison with phenylephrine (E and F), P \> 0.8 for interval points 50 µm. Error bars indicate SEM.](JCB_201310045_Fig6){#fig6}

We next asked whether inducible, activity-dependent dendritic transport can also be observed with naturally occurring mRNAs that contain ID3 or ID4 elements. As a representative of such mRNAs, we chose rat CLN2 (ceroid lipofuscinosis, neuronal 2; [@bib40]) mRNA, which contains an ID3 element in its 3′ UTR (3′ UTR nt 478--552; GenBank accession no. [NM_031357](NM_031357)). We found that this mRNA was not delivered to dendrites under basal steady-state conditions ([Fig. 6, A, B, and G](#fig6){ref-type="fig"}). However, CLN2 mRNA was transported along the dendritic extent upon K^+^-induced depolarization (not depicted) and upon activation of β-ARs with isoproterenol ([Fig. 6, C, D, and G](#fig6){ref-type="fig"}). In contrast, activation of α-ARs with phenylephrine did not induce dendritic delivery ([Fig. 6, E, F, and G](#fig6){ref-type="fig"}). The results further corroborate the notion that R•R-linked GA targeting motifs encode conditional dendritic transport competence as activity-dependent transport can be observed with chimeric reporter mRNAs and with naturally occurring mRNAs containing such motifs.

Conditional recognition by targeting factor hnRNP A2
----------------------------------------------------

We have previously shown that hnRNP A2 is a transport factor that recognizes the BC1 RNA GA targeting motif and that this interaction is necessary for the delivery of the RNA to dendrites ([@bib72], [@bib73]). Now, we asked whether conditional dendritic transport, mediated by ID3/ID4-type R•R-linked GA targeting motifs, equally relies on targeting factor hnRNP A2 and whether in these cases conditional recognition of such motifs by hnRNP A2 is the basis for conditional, activity-dependent dendritic targeting.

In addressing these questions, we took into consideration that β-adrenergic downstream modes of action in neurons involve PKA-mediated stimulation of Ca^2+^ influx through dendritic L-type voltage-dependent calcium channels (VDCCs; [@bib21]; [@bib7]; [@bib32]; [@bib33]). In view of these data, the possibility is raised that binding of ID3/ID4 GA targeting motifs by hnRNP A2 is Ca^2+^ dependent. We performed quantitative electrophoretic mobility shift assay (EMSA) analysis, as previously described ([@bib72], [@bib73]), to assess this possibility.

EMSA analysis revealed that hnRNP A2 binds to ID4 GA targeting motif RNA and that this binding is dynamically modulated by Ca^2+^ levels ([Fig. 7](#fig7){ref-type="fig"}). Binding is robust at 500 nM Ca^2+^ but significantly less so at Ca^2+^ levels above or below this optimum, thus defining a window of effective Ca^2+^ concentrations. Mg^2+^ was found ineffective in promoting binding except at concentrations of 1 mM or above ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201310045/DC1){#supp2}). These results differ from those obtained with BC1 RNA as in the latter case, binding to hnRNP A2 is promoted by Ca^2+^ and Mg^2+^ in the millimolar concentration range ([@bib73]). In contrast, for ID4 RNA, binding is promoted by Ca^2+^, but not by Mg^2+^, in the nanomolar concentration range. We next asked how Ca^2+^ levels impact the equilibrium dissociation constant (*K*~d~) for the interaction between hnRNP A2 and the ID4 GA targeting motif. To address this question, we titrated the ID4 GA targeting motif with increasing concentrations of hnRNP A2 at three levels of Ca^2+^ concentrations, selected according to the results shown in [Fig. 7 (A and B)](#fig7){ref-type="fig"}: 100 nM Ca^2+^, 500 nM Ca^2+^, and 2 µM Ca^2+^. Quantitative EMSA analysis was performed at each of these Ca^2+^ concentrations, and the data obtained were fitted to the Hill equation ([@bib86]; [@bib16]; [@bib73]). The following equilibrium dissociation constants were obtained: *K*~d~ = 280 nM at 100 nM Ca^2+^, *K*~d~ = 200 pM at 500 nM Ca^2+^, and *K*~d~ = 580 nM at 2 µM Ca^2+^. Equilibrium dissociation constants could not be established at Ca^2+^ concentrations \<20 nM or \>10 µM as no significant binding was detectable.

![**Ca^2+^-dependent interaction of ID4 mRNA with hnRNP A2.** In EMSA experiments using native PAGE, shifts to lower mobility reveal binding of radiolabeled RNAs to recombinant hnRNP A2. (A and B) Mobility shifts indicate that binding of ID4-chimeric α-tubulin mRNA to hnRNP A2 was dependent on Ca^2+^ levels. Maximal binding was observed at 500 nM Ca^2+^. Original data are shown on the left (A), and combined results from five experiments are shown in the diagram on the right (B). (C--H) Equilibrium binding constants were established in a series of experiments in which ID4-chimeric α-tubulin mRNA was titrated with increasing concentrations of hnRNP A2 at different concentrations of Ca^2+^. Original data are shown on the left (C, E, and G). The binding data were fitted to the Hill equation as previously described ([@bib86]; [@bib16]; [@bib73]) and were plotted in binding curves on the right (D, F, and H). Equilibrium dissociation constants were as follows: *K*~d~ = 280 nM at 100 nM Ca^2+^ (D), *K*~d~ = 200 pM at 500 nM Ca^2+^ (F), and *K*~d~ = 580 nM at 2 µM Ca^2+^ (H). Error bars indicate SEM.](JCB_201310045_Fig7){#fig7}

The results show that binding of hnRNP A2 to the ID4 GA targeting motif is of remarkably high affinity at 500 nM Ca^2+^. The affinity is significantly lower (by more than three orders of magnitude) at 100 nM Ca^2+^ and 5 µM Ca^2+^, and little binding was detectable below the former or above the latter Ca^2+^ concentrations. We conclude that binding of hnRNP A2 to the ID4 GA motif occurs only in a narrowly demarcated Ca^2+^ concentration window around 500 nM.

Ca^2+^-dependent dendritic delivery
-----------------------------------

Because the interaction of ID4 GA motif RNA with targeting factor hnRNP A2 is Ca^2+^ dependent, we hypothesized that the dendritic transport of ID4 RNA would also be a function of Ca^2+^ concentrations. In neurons, intracellular Ca^2+^ levels (\[Ca^2+^\]~i~) are low at 50--100 nM in the resting state but can transiently rise to 500--1,000 nM upon activation ([@bib5]; [@bib30]). Even higher transient levels may occur locally ([@bib74]; [@bib84]). It was thus conceivable that for ID4 GA motif RNA, induction of dendritic targeting requires transient elevation of \[Ca^2+^\]~i~. We performed two sets of experiments to test this possibility.

First, we induced dendritic transport of ID4 α-tubulin chimeric RNA with β-AR agonist isoproterenol, as shown in [Fig. 5](#fig5){ref-type="fig"}. In parallel experiments, isoproterenol was applied after preincubation with BAPTA-AM, a standard internal Ca^2+^ chelator ([@bib8]; [@bib78]). [Fig. 8](#fig8){ref-type="fig"} shows that isoproterenol-induced dendritic delivery of ID4 α-tubulin chimeric RNA was blocked by BAPTA-AM. Reduced ID4 GA motif targeting was also observed when BAPTA-AM was used in conjunction with neuronal depolarization (not depicted). The data suggest that intracellular Ca^2+^ is required for the β-adrenergic induction of ID4 GA motif conditional targeting.

![**Ca^2+^-dependent dendritic transport of ID4 mRNA.** (A and B) ID4-chimeric α-tubulin mRNA was delivered to dendrites of sympathetic neurons after β-adrenergic activation with isoproterenol. (C and D) In contrast, little dendritic transport was observed when the β-adrenergic agonist isoproterenol was applied after preincubation with the intracellular Ca^2+^ chelator BAPTA-AM. Number of cells analyzed: (A and B) 16 cells, 67 dendrites; (C and D) 15 cells, 60 dendrites. Bar, 50 µm. (E) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels in the basal state \[[Fig. 2](#fig2){ref-type="fig"}\] with RNA levels after β-adrenergic activation and with levels after β-adrenergic activation in the presence of BAPTA-AM): comparison with isoproterenol (A and B), P \< 0.001 for all interval points; comparison with isoproterenol/BAPTA-AM (C and D), P \> 0.8 for interval points 50 µm. Error bars indicate SEM.](JCB_201310045_Fig8){#fig8}

β-Adrenergic signaling in dendrites entails influx of Ca^2+^ through the L-type VDCC Ca~v~1.2 ([@bib21]; [@bib36]; [@bib7]; [@bib32]). Therefore, in a second set of experiments, we activated β-ARs in the presence of L-type VDCC blockers nimodipine/nifedipine. [Fig. 9](#fig9){ref-type="fig"} shows that isoproterenol-induced dendritic delivery of ID4 α-tubulin chimeric RNA was significantly reduced in the presence of nimodipine ([Fig. 9, C and D](#fig9){ref-type="fig"}) or nifedipine ([Fig. 9, E and F](#fig9){ref-type="fig"}). To examine the possibility that chelation of intracellular Ca^2+^ by BAPTA-AM, or blockade of Ca^2+^ influx through L-type VDCCs, may have caused a general defect in dendritic RNA targeting, we investigated dendritic transport of PKMζ mRNA under such conditions. We have previously shown that PKMζ mRNA is constitutively targeted to dendrites and that a standard GA motif is responsible for distal dendritic delivery ([@bib71]). We now find that dendritic targeting of PKMζ mRNA is not stimulated after β-adrenergic activation and is unaltered in the presence of BAPTA-AM or nifedipine ([Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201310045/DC1){#supp3}). These results suggest that β-adrenergic stimulation and Ca^2+^ dependence are characteristics of dendritic ID4 GA motif targeting but not of dendritic GA motif targeting in general. In summary, the aforementioned data indicate that dendritic transport of ID4 GA motif RNA is induced by β-adrenergic activation via influx of Ca^2+^ through L-type VDCCs.

![**Conditional dendritic targeting dependent on influx of Ca^2+^ through VDCCs.** (A and B) ID4-chimeric α-tubulin mRNA was delivered to dendrites of sympathetic neurons after β-adrenergic activation. (C--F) Dendritic transport was significantly reduced if β-adrenergic activation occurred in the presence of L-type VDCC blocker nimodipine (C and D) or nifedipine (E and F). Number of cells analyzed: (A and B) 16 cells, 57 dendrites; (C and D) 19 cells, 80 dendrites; (E and F) 20 cells, 78 dendrites. Bar, 50 µm. (G) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels after β-adrenergic activation with RNA levels after β-adrenergic activation in the presence of nimodipine or nifedipine): comparison with nimodipine (C and D), P \< 0.001 for all interval points; comparison with nifedipine (E and F), P \< 0.01 for all interval points. Error bars indicate SEM.](JCB_201310045_Fig9){#fig9}

Activity-dependent dendritic delivery of endogenous CLN2 mRNA
-------------------------------------------------------------

The aforementioned data raise the question whether β-adrenergic activation will also induce Ca^2+^-dependent dendritic targeting of native (i.e., endogenous) ID3/ID4-carrying neuronal mRNAs. To address this question, we performed in situ hybridization ([@bib70], [@bib73]) with probes specific for ID3-carrying rat CLN2 mRNA. These experiments were performed with both hippocampal ([@bib70]) and sympathetic ([@bib73]) neurons in culture.

In hippocampal neurons, β-adrenergic activation has been shown to stimulate Ca^2+^ influx through dendritic L-type VDCCs ([@bib21]; [@bib36]; [@bib7]; [@bib32]). We now asked whether β-adrenergic activation can induce dendritic delivery of endogenous CLN2 mRNA in hippocampal neurons in culture. Results shown in [Fig. 10](#fig10){ref-type="fig"} indicate that this is indeed the case. Endogenous CLN2 mRNA remained restricted to neuronal somata under basal conditions ([Fig. 10, A and B](#fig10){ref-type="fig"}) but was found distributed along dendrites, from soma to distal dendritic tips after activation of β-ARs with agonist isoproterenol ([Fig. 10, C and D](#fig10){ref-type="fig"}). β-Adrenergic induction of CLN2 mRNA transport was prevented by intracellular Ca^2+^ chelation with BAPTA-AM ([Fig. 10, E and F](#fig10){ref-type="fig"}), by blockade of L-type VDCCs with nifedipine ([Fig. 10, G and H](#fig10){ref-type="fig"}) and by blocking β-ARs with antagonist propranolol (not depicted). Analogous results were obtained when in situ hybridization directed at endogenous CLN2 mRNA was performed with sympathetic neurons in culture ([Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201310045/DC1){#supp4}). These data establish that in both hippocampal and sympathetic neurons, the dendritic delivery of a native, ID3-carrying neuronal mRNA is inducible by β-adrenergic activation and is dependent on influx of Ca^2+^ through L-type VDCCs.

![**Induction of endogenous CLN2 mRNA transport by β-adrenergic activation in hippocampal neurons.** In situ hybridization was performed with a probe specific for rat CLN2 mRNA. (A and B) Hybridization signal (white silver grains) indicates somatic localization of endogenous CLN2 mRNA under basal conditions. (C and D) After activation of β-ARs with agonist isoproterenol, CLN2 mRNA was found localized along the entire dendritic extent. (E--H) Preincubation of cells with intracellular Ca^2+^ chelator BAPTA-AM (E and F) or with L-type VDCC blocker nifedipine (G and H) prevented isoproterenol-induced dendritic delivery of CLN2 mRNA. (I and J) Little or no signal was detectable when in situ hybridization was performed with a CLN2 mRNA "sense strand" control probe. Number of cells analyzed: (A and B) 14 neurons, 71 dendrites; (C and D) 14 neurons, 72 dendrites; (E and F) 11 neurons, 53 dendrites; (G and H) 12 neurons, 60 dendrites. Bar, 50 µm. (K) Quantitative analysis. One-way ANOVA, Dunnett's post hoc analysis (comparison of RNA levels in the basal state with RNA levels after β-adrenergic activation and after β-adrenergic activation in the presence of BAPTA-AM or nifedipine): comparison with isoproterenol (C and D), P \< 0.001 for all interval points; comparison with isoproterenol/BAPTA-AM (E and F), P \> 0.6 for interval points 50 µm; comparison with isoproterenol/nifedipine (G and H), P \> 0.7 for interval points 50 µm. Error bars indicate SEM.](JCB_201310045_Fig10){#fig10}

Discussion
==========

A wealth of new structural and functional data has over the last decade resulted in the identification of various novel classes of protein-engaging RNA motifs ([@bib92]; [@bib76]; [@bib57]). Leading this development have been major advances in the field of ribosome structure and function ([@bib76]; [@bib29]). As a result of these and related discoveries in RNA biology, it is now recognized that, except for exclusively protein-coding regions, it is often architectural RNA motifs---rather than nucleotide sequences per se---that are subject to natural selection in evolution ([@bib57]). Such motifs often serve as recognition sites for proteins, and their structural gestalt is typically determined by noncanonical nucleotide interactions ([@bib56]; [@bib76]; [@bib57]; [@bib29]).

Here, we report that a newly identified type of noncanonical RNA motif, the R•R-linked GA motif, encodes conditional dendritic targeting competence. The motif, which is contained in ID3 and ID4 elements, is organized around a core of noncanonical G•A/A•G pairs. This core in turn is clamped by WC pairs, typically of the G=C type. Directly adjoining this structure is a noncanonical purine•purine pair that is critical for targeting conditionality. Recognition of this motif by the targeting factor hnRNP A2 is strongly dependent on Ca^2+^ levels. At 500 mM Ca^2+^, the motif binds to hnRNP A2 with a uniquely high affinity of *K*~d~ = 200 pM. At Ca^2+^ levels above or below this optimal concentration, binding is significantly lower if at all detectable. GA motifs are known to be dimorphic as they exist in an equilibrium between an extended and a kinked conformation. Divalent cations promote transition to the latter conformation, which binds cognate proteins with high affinity ([@bib60]; [@bib27]; [@bib17]; [@bib58]; [@bib82]; [@bib26]; [@bib88]). Binding to a cognate protein will in turn arrest the motif in the high-affinity conformation ([@bib98]). However, although such binding dynamics have been described for standard GA motifs, a narrow-window Ca^2+^ dependence, as described here, appears to be a feature specific to R•R-linked GA motifs. It is possible that the GA-proximal additional R•R content introduces conformational motif flexibility that is Ca^2+^ driven. Although a formal test of this hypothesis will require structural approaches, we propose that motif affinity to hnRNP A2 is directly Ca^2+^ dependent and that Ca^2+^ levels in the 500-nM range promote transition from a low-affinity to the high-affinity conformation.

R•R-linked GA motifs are contained in ID3 and ID4 mRNAs. Working with ID3/ID4 chimeric reporter mRNAs as well as with a naturally occurring ID3 mRNA, we found that dendritic targeting is inducible by neuronal depolarization and by receptor activation. Specifically, β-adrenergic activation (but not α-adrenergic activation) induces long-range delivery along the entire dendritic extent. β-Adrenergic transport induction is dependent on influx of Ca^2+^ through L-type VDCCs. β-ARs have previously been implicated in neuronal function and plasticity ([@bib37]; [@bib81]; [@bib65]). In hippocampal neurons, β-ARs have been shown to form signaling complexes with L-type VDCCs, G proteins, adenylyl cyclase, and PKA, indicating that localized signal transduction couples receptors to channels ([@bib21]; [@bib100]; [@bib32]). Ca^2+^ influx is thus a direct consequence of β-adrenergic activation. In both sympathetic and hippocampal neurons, our data indicate that native and introduced ID3/ID4-bearing mRNAs are targeted to dendrites after β-adrenergic activation. In both cell types, β-adrenergic induction of ID3/ID4 mRNA transport is dependent on influx of Ca^2+^ through L-type VDCCs.

A transient rise in postsynaptic \[Ca^2+^\]~i~ can trigger intracellular Ca^2+^ waves that propagate along dendrites toward the soma, and these Ca^2+^ transients can reach \[Ca^2+^\]~i~ amplitudes of 1 µM or more in both somata and dendrites ([@bib5]; [@bib30]; [@bib84]). Any such Ca^2+^ transient, once it reaches a local threshold of 500 nM, will cause a switch to the high-affinity conformation of the GA targeting motif and thus enable binding of hnRNP A2. The question is then raised how a rapid rise and fall in \[Ca^2+^\]~i~ can lead to prolonged dendritic transport (which operates on a slower time frame). We surmise that binding of hnRNP A2 to the high-affinity motif conformation will in turn fix this conformation (as has previously been reported for GA motifs; [@bib98]), as a result locking the protein on the RNA and thus supporting sustained transport even after local \[Ca^2+^\]~i~ has returned to basal resting levels.

Retroposition is a mechanism of intragenomic transfer that has been a ubiquitous and innovative force in the remodeling of eukaryotic genomes ([@bib9], [@bib11]; [@bib34]; [@bib44]; [@bib18]). Retroposition has been responsible for the genomic dissemination of numerous 5′ BC1-derived ID elements ([@bib47]). A partial list of such elements has been established, and dendritic targeting has been confirmed for selected representatives ([@bib13]). In earlier work, in contrast, ID or BC1 chimeric RNAs were not seen localized to dendrites in a conventional transgenic mouse system ([@bib45]). However, the expression of GA motif RNAs at high levels for prolonged periods of time, as is the case in such animals, can trigger cellular anti-dsRNA mechanisms ([@bib43]; [@bib79]). Potent inducers of such mechanisms, which likely have evolved as components of antiviral defense strategies, are noncanonical GA motifs ([@bib6]). Of note, the HIV-1 (human immunodeficiency virus type 1) Rev response element contains a GA motif ([@bib39]) that is similar to those in BC RNAs.

For a dissection of dendritic targeting competence in naturally occurring ID-containing mRNAs, we chose as a representative CLN2 mRNA that contains in its 3′ UTR an ID3 targeting element with a G•G-linked GA motif. We established that this RNA is delivered to dendrites conditionally, i.e., upon induction by depolarization or β-AR activation. CLN2 mRNA encodes TPP1 (tripeptidyl peptidase 1), a soluble lysosomal serine protease ([@bib40]). Lysosomes are located to dendrites in cultured neurons and in vivo during neurodevelopment ([@bib83]; [@bib75]; [@bib53], [@bib54]), suggesting that associated RNA transport is a developmental mechanism. Reduced TPP1 activity is causative of late infantile neuronal ceroid lipofuscinosis ([@bib40]; [@bib50]), and future work will investigate whether dysregulated RNA transport contributes to disease manifestations, such as ataxia and seizures.

Because the retroposition mechanism has been shaping the phylogenetic diversification of a large number of mammalian genes, we expect ID dissemination to be only one out of several retroposition dispersals that have provided neuronal genes with constitutive and conditional targeting codes. In primates, retroposons of the Alu-J type are homologous to the 5′ BC200 domain ([@bib95]). BC200 RNA localizes to dendrites in human brain ([@bib95]) and is also delivered to dendrites of rat cultured neurons after microinjection ([@bib73]). BC200 RNA and G22 RNA (a prosimian Alu-related nonprotein-coding RNA) were also found localized in dendritic fields of transgenic mouse brains ([@bib46]). BC200 RNA interacts with hnRNP A2 via a 5′ GA motif ([@bib73]; unpublished data). Alu-J elements are highly similar to the 5′ BC200 domain, with the critical difference of additional GA-proximal R•R content ([@bib95]; [@bib89]). Such an R•R-linked GA motif is contained in human CLN2 mRNA, and we found that this RNA is delivered to dendrites in a conditional manner (unpublished data). We therefore posit that the constitutive BC1-conditional ID relationship is mirrored in an analogous BC200--Alu relationship. On the other hand, and in contrast to rat CLN2 mRNA, murine CLN2 mRNA appears to be lacking an ID element or other GA motifs that may serve as dendritic targeting elements. Species-specific acquisition of RNA targeting competence has previously been described by us ([@bib19]) and by others ([@bib13]). The combined evidence provides further support for the notion that the functional recruitment of mobile elements may be a determinant in the evolutionary diversification of neural systems.

Conditional dendritic targeting can also be encoded by R•R-linked GA motifs that are not formal members of the ID or Alu retroposon families. Dendritic delivery of brain-derived neurotrophic factor mRNA and CaMKIIα mRNA is constitutive at low levels ([@bib14]; [@bib2]) but can be induced by application of neuronal stimuli, as was shown by use of depolarization in the former and receptor activation in the latter case ([@bib96]; [@bib23]). Both mRNAs contain GA motifs that, while sharing key attributes with ID GA motifs, feature two R•R pairs proximal to the GA core, rather than the single proximal R•R pair that is seen in ID3/ID4. In both cases, motif structure is conserved between rodent and primate mRNAs. While future work will address the significance of these GA motifs for inducible dendritic targeting, we propose that a common principle is at work in neuronal RNA transport: while noncanonical GA motifs serve as dendritic targeting elements, additional proximal R•R content renders targeting conditional.

The activity-dependent dendritic delivery of GA motif RNAs enables neurons to supply postsynaptic microdomains with requisite RNAs on demand. Work presented here indicates that a Ca^2+^-dependent switch to the high-affinity GA motif conformation promotes interaction with the targeting machinery and, consequently, sustained dendritic transport. How then is RNA cargo discharged upon arrival at a synaptodendritic destination? Although speculative at this time, it is tempting to hypothesize that docking of the RNA transport complex at a target site will trigger reversion to the low-affinity GA motif conformation and consequently dissolution of the RNA--protein targeting complex. We invite research to test this hypothesis.

Materials and methods
=====================

Plasmids and RNA preparation
----------------------------

WT BC1 RNA was transcribed from plasmid pBCX607 by T7 RNA polymerase after linearization with DraI ([@bib72], [@bib73]). Analogously, the following plasmids, derived from pBCX607, were used to express mutant forms of BC1 RNA (respective mutations indicated by subscript): pBC1~U5C~, pBC1~U67C~, pBC1~U5C/U67C~, pBC1~G35A~, pBC1~C41G~, and pBC1~G35A/C41G~. ID-chimeric α-tubulin mRNAs were generated as follows. pTub-A98/TA2 was used to transcribe α-tubulin mRNA with an 98-nt poly(A) tail 3′ to the protein-coding sequence. An analogous, chimeric α-tubulin mRNA with an ID1 element (5′ BC1 domain) inserted between the protein-coding sequence and A98 was transcribed from pTID1D/T1, with an inserted ID2 element from pTID2D/T3-D, with an inserted ID3 element from pTID3D/T3, with an inserted ID4 element from pTID4D/T1-B, and with an inserted reverse complementary ID4 element from pTID4R/T2-13. These plasmids were constructed using the pBlueScript II SK+ RNA transcription kit (Agilent Technologies). They were linearized with XbaI, and transcripts were generated with SP6 RNA polymerase. CLN2 mRNA was generated from pBluescript-CLN2 (obtained from R. Crystal, Weill Cornell Medical College, New York, NY; [@bib91]). The plasmid was linearized with SacI and transcribed with T7 RNA polymerase. For in situ hybridization, a CLN2 mRNA segment (nt 327--822) was recloned into pBluescript II SK between the SmaI and XbaI sites to give pBluescript-CLN2is. pET-9c/A2 was used to express recombinant full-length hnRNP A2 (obtained from R. Smith, University of Queensland, Brisbane, Queensland, Australia; [@bib67]; [@bib73]). The pET-9c vector (pBR322 origin and T7 promoter; EMD Millipore) was used to construct this plasmid. The hnRNPA2 expression plasmids were generated from two separate RT-PCR fragments ([@bib61]). C- and N-terminal fragments were purified and ligated together into pET-9c digested with NdeI and BamHI. For PKMζ mRNA microinjection experiments, a segment of 1,935 nt was generated from plasmid PKMζ-(48--1,982) ([@bib71]), representing PKMζ mRNA nt 48--1,982, inserted between the HindIII and XbaI sites in pBlueScript SK(−) (Agilent Technologies). The plasmid was linearized with XbaI and transcribed with T7. Size and integrity of all transcripts was ascertained by clear native PAGE.

Cell culture, microinjection, and in situ hybridization
-------------------------------------------------------

Low-density primary cultures of sympathetic neurons were generated and maintained as follows (previously described in [@bib35]; [@bib72], [@bib73]). Superior cervical ganglia were isolated from embryonic day 19 (E19)--E21 Sprague--Dawley rat embryos. Ganglia were dissociated by mechanical and enzymatic treatment (20 min at 37°C; TrypLE Express; Life Technologies), and neurons were plated and maintained on glass coverslips (Carolina Biological Supply) precoated with 100 mg/ml filter-sterilized poly-[d]{.smallcaps}-lysine (Sigma-Aldrich). Basic culture media contained a 50% (vol/vol) mixture of Ham's F12 medium and DMEM (both from Life Technologies) supplemented with 500 µg/ml BSA (EMD Millipore), 10 µg/ml bovine insulin (Sigma-Aldrich), 20 µg/ml rat transferrin (Jackson ImmunoResearch Laboratories, Inc.), 20 µg/ml [l]{.smallcaps}-glutamine (Life Technologies), 5 ng/ml sodium selenite (Sigma-Aldrich), and 100 ng/ml β-NGF (Harlan Bioproducts for Science, Inc.). Neurons were grown at 35°C in an atmosphere of 5% CO~2~. Basement membrane extract (100 µg/ml; Matrigel; Collaborative Biomedical Products) was added on the third day in vitro to induce dendritic growth. Growth of nonneuronal cells was minimized by adding 2 µM Ara-C (cytosine arabinofuranoside; Sigma-Aldrich) on the second and fifth days after plating. Work with vertebrate animals was approved by the State University of New York Downstate Medical Center Institutional Animal Care and Use Committee.

Primary cultures of hippocampal neurons were prepared as follows (previously described by [@bib28]; [@bib70]). Hippocampal brain tissue was prepared from E18--E19 Sprague--Dawley rat embryos. Cells were dissociated by mechanical and enzymatic treatment (20 min at 37°C; TrypLE Express) and plated on poly-[l]{.smallcaps}-lysine--precoated glass coverslips in MEM with 10% horse serum (Life Technologies) and 0.6% [d]{.smallcaps}-glucose (Sigma-Aldrich). After 4 d, cells were transferred to dishes containing monolayer cultures of astroglia. Neuronal and glial layers were facing each other without being in physical contact. Cells were then maintained in serum-free medium: MEM, 0.5 mg/ml N-2 supplement, 10 mM Hepes supplemented with 100 µg/ml rat transferrin (Jackson ImmunoResearch Laboratories, Inc.), 10 µg/ml insulin (Sigma-Aldrich), 20 nM progesterone (Sigma-Aldrich), 5 ng/ml sodium selenite (Sigma-Aldrich), 100 µM putrescine (Sigma-Aldrich), 0.1% ovalbumin (Sigma-Aldrich), and 1 mM sodium pyruvate (Sigma-Aldrich). Astroglial cell cultures were prepared from neonatal rat cerebral hemispheres dissected in a dish with Hepes-buffered, Ca^2+^- and Mg^2+^-free balanced salt solution. Cells were dissociated by mechanical and enzymatic treatment and plated onto 22-mm glass coverslips, arranged in 60-mm dishes for co-culturing with neurons. 5 µM Ara-C was added on the fifth day to reduce glial proliferation.

To depolarize neurons in culture, cells were maintained in media containing 30 mM KCl, as previously described ([@bib93]; [@bib3]; [@bib31]) beginning 15 min before microinjection. Adrenergic agonists/antagonists were used as follows with cultured neurons: 10 µM isoproterenol ([@bib63]), 10 µM phenylephrine ([@bib55]), and 10 µM propranolol ([@bib1]). The membrane-permeable Ca^2+^ chelator BAPTA-AM was used at 50 µM ([@bib8]). Ca^2+^ channel blockers nifedipine and nimodipine were used at 10 µM ([@bib59]; [@bib99]). Agonists were applied 15--30 min before microinjection. Antagonists, Ca^2+^ chelators, and Ca^2+^ channel blockers were applied ≥30 min before agonists ([@bib4]). Agonists, antagonists, Ca^2+^ chelators, and Ca^2+^ channel blockers were purchased from Sigma-Aldrich.

Microinjection of sympathetic neurons in culture was performed as follows (previously described in [@bib69], [@bib71], [@bib72], [@bib73]). RNAs (^35^S radiolabeled at 3 × 10^6^ cpm/µl) were microinjected, typically into cell perikarya, at volumes of a few femtoliters per pulse. Nuclear injections were performed to examine whether a "nuclear experience" was required for targeting ([@bib102]). No such case was observed. For each RNA, injection amounts were varied over a concentration range of at least one order of magnitude to ensure that observed dendritic targeting patterns were independent of amounts injected ([@bib72], [@bib73]). We routinely co-inject 0.4% Lucifer yellow to monitor the injection process and to ascertain that injection and experimental conditions (e.g., application of agonists, antagonists, and Ca^2+^ chelators) are not causing alterations in cell morphology, including dendritic extent and arborization ([@bib72]). The postinjection incubation period varied between 1 and 3 h. Although 1 h was found sufficient for GA motif RNAs to reach distal dendritic tips, a range of incubation periods was used to establish that transport velocities were constant ([@bib72]), i.e., did not vary between different transported RNAs and were not a function of experimental paradigms, such as receptor activation or blockade. For each transcript, RNA stability was monitored preinjection by PAGE and postinjection by measuring average integrated total signal intensities per injected cell ([@bib72], [@bib73]). Relative RNA stability was also ascertained by incubation with brain extract ([@bib73]).

Neurons on coverslips were fixed, dipped in photographic emulsion (NTB-2; Kodak), and exposed at 4°C for 3--4 wk. Microscopy was performed after processing with a developer (50% strength; D-19; Kodak) and a liquid fixer (Rapid Fixer; Kodak).

Microinjection of radiolabeled transcripts is our preferred method to introduce RNAs into cells for two reasons. (1) We found microinjection superior to other delivery methods as it allows unparalleled control of amounts of RNA introduced. In combination with the high sensitivity of radiolabel detection, this approach enables us to keep the number of introduced RNA molecules lower than the number of respective endogenous RNA molecules ([@bib72]). (2) Microinjection of radiolabeled RNAs is preferred because architectural GA motifs are intolerant of nucleotide substitutions ([@bib27]), and introduced side chains (such as fluorophores) may sterically interfere with motif structure and cause altered targeting ([@bib73]). We have developed methodology to quantify dendritic RNA transport both spatially and temporally ([@bib72], [@bib73]).

In situ hybridization was performed with hippocampal neurons in culture ([@bib70]) and with sympathetic neurons in culture ([@bib73]) as previously described. ^35^S-labeled RNA probes directed at rat CLN2 mRNA were generated from plasmid pBluescript-CLN2is (see Plasmids and RNA preparation). To generate antisense-strand probes, the plasmid was linearized with PstI and transcribed with T3 RNA polymerase. To generate sense-strand probes, the plasmid was linearized with SacI and transcribed with T7 RNA polymerase. Probes were ^35^S labeled. Prehybridization and hybridization steps were performed as described with high stringency washes performed at 50°C ([@bib70], [@bib73]). In brief, fixed neurons were placed in hybridization boxes containing filter paper saturated with box buffer (4× SSC and 50% formamide). For prehybridization, a small amount of hybridization buffer (10 mM DTT, 0.3 M NaCl, 20 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, Denhardt's solution, 10% dextran sulfate, and 50% formamide) was added to cover cells. Cells were prehybridized for 1 h at 42°C. The hybridization mixture contained 2 µl ^35^S-labeled riboprobe (300,000 cpm/µl in Tris-EDTA) and 1 µl tRNA per 100 µl prehybridization buffer. Hybridization was performed overnight at 42°C. After hybridization, slides with coverslips were rinsed twice for 10 min each at room temperature in 2× SSC containing 0.1% β-mercaptoethanol and 1 mM EDTA followed by RNase A treatment (20 µg/ml in 500 mM NaCl and 10 mM Tris-HCl, pH 8.0; Sigma-Aldrich) for 30 min at room temperature. Cells were rinsed twice with 2× SSC containing 0.1% β-mercaptoethanol and 1 mM EDTA at room temperature followed by a high stringency wash in 4 liters of 0.2× SSC containing 0.1% β-mercaptoethanol and 1 mM EDTA at 42°C for 4 h. Slides were washed twice with 0.2× SSC at room temperature. Neurons were dehydrated in graded alcohol containing 0.3 M ammonium acetate, and dried in a vacuum desiccator.

For emulsion autoradiography, dried coverslips were mounted, cell side up, on microscope slides and dipped in NTB-2 emulsion as previously described ([@bib70], [@bib73]). Cells were exposed at 4°C for 7 d (microinjection) or 3--4 wk (in situ hybridization) before photographic development (D-19 developer, 50% strength; Rapid Fixer) as previously described ([@bib70], [@bib73]).

Microscopy, data acquisition, and analysis
------------------------------------------

Photomicrographs (dark field and phase contrast) were taken on a microscope (Microphot-FXA; Nikon) with a camera (Digital-Sight DS-Fi1; Nikon). Photographs were taken of fixed specimens (cultured neurons mounted on coverslips) at room temperature using the following objectives: (a) Plan Fluor 10×/0.30 NA and 160×/0.17 NA; (b) PhC Plan 20×/0.50 NA and DL 160×/0.17 NA; (c) Plan 20×/0.50 NA and differential interference contrast 160×/0.17 NA; and (d) Ph3 DL Plan 40×/0.65 NA and 160×/0.17 NA. To evaluate transport of injected RNAs, silver grains were measured along dendritic shafts at 50-µm interval points, up to 250 µm ([@bib72], [@bib73]). Signal intensities at the base of dendrites (0-µm points) were given a relative value of 100%. MetaMorph software (Molecular Devices) was used for image analysis. DeltaGraph 5 software (Red Rock Software) was used to design bar diagrams. Final illustrations were arranged in Illustrator (Adobe). SPSS software (IBM) was used for statistical analysis. All experiments were performed at least in quadruplicate or as noted in the figure legends.

Expression of recombinant proteins
----------------------------------

Expression and purification of recombinant hnRNP A2 was performed as described ([@bib67]; [@bib73]). *Escherichia coli* BL21(DE3) was transformed with plasmid pET-9c/A2 to express hnRNP A2. Cells were induced with isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside. Harvested by centrifugation, cells were lysed in 50 mM Tris-HCl, pH 8, 2 mM EDTA, 100 µg/ml lysozyme, and 0.1% Triton X-100. Buffer A (50 mM Tris-HCl, pH 8.5, 0.2 mM EDTA, and 5% wt/vol glycerol) was used for dialysis of the soluble fraction. Chromatography was performed on diethylaminoethyl cellulose (GE Healthcare) and, subsequently, on Sephacryl S-300 (GE Healthcare) and, for further purification, on a C4 reverse-phase HPLC column (Vydac) using a linear 10--50% acetonitrile gradient in 0.1% trifluoroacetic acid. After lyophilization, hnRNP A2 was dissolved in water. Protein identity and purity was ascertained by SDS-PAGE and by electrospray mass spectrometry on a spectrometer (Sciex 165; PerkinElmer).

Native PAGE and EMSA
--------------------

Clear native PAGE and EMSA were performed as previously described ([@bib27]; [@bib72], [@bib73]). 4--20% Mini-PROTEAN TGX Stain-Free PAGE gels were used (Bio-Rad Laboratories). ^32^P-labeled RNA probes (50,000 cpm/reaction) were heated for 10 min at 70°C and allowed to cool for 5 min at room temperature. Probes were incubated for 20 min at room temperature together with proteins in binding buffer (300 mM KCl, 5 mM MgCl~2~, 2 mM DTT, 5% glycerol, and 20 mM Hepes, pH 7.6). The samples were electrophoresed at room temperature at 120 V and 25 mA. RNA--protein complexes were visualized by autoradiography. To quantify results, a phosphorimaging system (Storm 860) and ImageQuant software were used (GE Healthcare). Binding affinities were established by measuring the fractions of free versus bound RNA. The Hill equation was used to determine equilibrium constants ([@bib86]; [@bib16]; [@bib73]).

Online supplemental material
----------------------------

Fig. S1 shows control experiments in which a reverse complementary ID4 (ID4R) RNA is not delivered to dendrites under either basal or stimulation conditions. Fig. S2 provides evidence that binding of ID4 RNA to hnRNP A2 is not promoted by Mg^2+^ at concentrations \<1 mM. Fig. S3 shows that dendritic transport of PKMζ mRNA, which depends on a 3′ UTR standard GA motif, is constitutive and remains unaltered under conditions of Ca^2+^ chelation or L-type VDCC blockade. Fig. S4 documents that dendritic delivery of endogenous CLN2 mRNA is induced by β-adrenergic activation in sympathetic neurons in culture and that such transport induction is prevented by chelation of intracellular Ca^2+^ and L-type VDCC blockade. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201310045/DC1>.
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